您的位置: 首页 > 农业专利 > 详情页

2-CYANOISOINDOLINE DERIVATIVES FOR TREATING CANCER
专利权人:
MISSION THERAPEUTICS LIMITED
发明人:
Karl Richard GIBSON,Alison JONES,Mark Ian KEMP,Andrew MADIN,Martin Lee STOCKLEY,Gavin Alistair WHITLOCK,Michael D WOODROW,Keith Allan MENEAR
申请号:
US16080506
公开号:
US20190010122A1
申请日:
2017.03.17
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The invention relates to novel compounds of formula I which are inhibitors of deubiquitylating enzymes (DUBs) and/or desumoylating enzymes. In particular, the invention relates to the inhibition of ubiquitin C-terminal hydrolase 7 or ubiquitin specific peptidase 7 (USP7). The invention further relates to methods for the preparation of these compounds and to their use in the treatment of cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充